Sfoglia per Autore
Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas.
2006 Bonora E.; Evangelisti C.; Bonichon F.; Tallini G.; Romeo G.
C620R mutation of the murine ret proto-oncogene: loss of function effect in homozygotes and possible gain of function effect in heterozygotes.
2007 Yin L.; Puliti A.; Bonora E.; Evangelisti C.; Conti V.; Tong WM.; Medard JJ.; Lavoué MF.; Forey N.; Wang LC.; Manié S.; Morel G.; Raccurt M.; Wang ZQ.; Romeo G.
Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia.
2009 A.M. Martelli; C. Evangelisti; F. Chiarini; C. Grimaldi; L. Manzoli; J.A. McCubrey.
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
2010 Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM.
Apolipoprotein B is a new target of the GDNF/RET and ET-3/EDNRB signalling pathways
2012 C. Evangelisti;F. Bianco;L. M. Pradella;A. Puliti;A. Goldoni;I. Sbrana;M. Rossi;M. Vargiolu;M. Seri;G. Romeo;V. Stanghellini;R. de Giorgio;E. Bonora
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia
2013 Lucia Catani;Daria Sollazzo;Sara Trabanelli;Antonio Curti;Cecilia Evangelisti;Nicola Polverelli;Francesca Palandri;Michele Baccarani;Nicola Vianelli;Roberto Massimo Lemoli
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia.
2013 C. Evangelisti; C. Evangelisti; D. Bressanin; F. Buontempo; F. Chiarini; A Lonetti; M Soncin; A.M. Spartà; J. A. McCubrey; A.M. Martelli.
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS
2014 Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Bressanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES
2014 Buontempo F; Orsini E; Cappellini A; Lonetti A; Evangelisti C; Chiarini F; Spartà AM; Bressanin D; Evangelisti C; Martelli AM
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer.
2014 Pradella LM;Evangelisti C;Ligorio C;Ceccarelli C;Neri I;Zuntini R;Amato LB;Ferrari S;Martelli AM;Gasparre G;Turchetti D
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS
2014 Evangelisti C; Evangelisti C; Teti G; Falconi M; Cappellini A; Chiarini F; Buontempo F; Bressanin D; Lonetti A; Spartà A; Bittman R; Pyne S; Pyne N; Martelli AM
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS
2014 Lonetti A; Cappellini A; Spartà AM; Bressanin D; Buontempo F; Chiarini F; Evangelisti C; Evangelisti C; Orsini E; Martelli AM
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling
2014 F. Buontempo; E. Orsini; L.R. Martins; I. Antunes; A. Lonetti; F. Chiarini; G. Tabellini; C. Evangelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A. Cappellini; J.T. Barata; A.M. Martelli.
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.
2014 Trabanelli S; Očadlíková D; Ciciarello M; Salvestrini V; Lecciso M; Jandus C; Metz R; Evangelisti C; Laury-Kleintop L; Romero P; Prendergast GC; Curti A; Lemoli RM.
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia
2014 Camilla Evangelisti; Cecilia Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontempo; Daniela Bressanin; Alessandra Cappellini; Ester Orsini; James A. McCubrey; Alberto Maria Martelli.
Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics.
2014 C. Evangelisti; C. Evangelisti; G. Teti; F. Chiarini; M. Falconi; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; D. J. Beak; R. Bittman; S. Pyne; N.J. Pyne; A.M. Martelli.
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia.
2014 A.M. Spartà; D. Bressanin; F. Chiarini; A. Lonetti; A. Cappellini; C. Evangelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A.M. Martelli.
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors.
2015 Annalisa Lonetti, Alessandra Cappellini, Antonino Maria Spartà, Francesca Chiarini, Francesca Buontempo, Camilla Evangelisti, Cecilia Evangelisti, Ester Orsini, James A. McCubrey, Alberto Maria Martelli
A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors
2015 Cecilia Evangelisti;Dario de Biase;Ivana Kurelac;Claudio Ceccarelli;Holger Prokisch;Thomas Meitinger;Paola Caria;Roberta Vanni;Giovanni Romeo;Giovanni Tallini;Giuseppe Gasparre;Elena Bonora
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications.
2015 Cecilia Evangelisti; Camilla Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontempo; Luca Maria Neri; James A. McCubrey; Alberto Maria Martelli.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas. | Bonora E.; Evangelisti C.; Bonichon F.; Tallini G.; Romeo G. | 2006-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| C620R mutation of the murine ret proto-oncogene: loss of function effect in homozygotes and possible gain of function effect in heterozygotes. | Yin L.; Puliti A.; Bonora E.; Evangelisti C.; Conti V.; Tong WM.; Medard JJ.; Lavoué MF.; Forey N....; Wang LC.; Manié S.; Morel G.; Raccurt M.; Wang ZQ.; Romeo G. | 2007-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Targeting the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in acute myelogenous leukaemia. | A.M. Martelli; C. Evangelisti; F. Chiarini; C. Grimaldi; L. Manzoli; J.A. McCubrey. | 2009-01-01 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | - | 1.01 Articolo in rivista | - |
| Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. |
Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S...; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM. |
2010-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | Indoleamine 2,3-Dioxygenase-Expressing Leukemic Dendritic Cells.pdf; 025924.Curti_suppl.pdf |
| Apolipoprotein B is a new target of the GDNF/RET and ET-3/EDNRB signalling pathways | C. Evangelisti;F. Bianco;L. M. Pradella;A. Puliti;A. Goldoni;I. Sbrana;M. Rossi;M. Vargiolu;M. Se...ri;G. Romeo;V. Stanghellini;R. de Giorgio;E. Bonora | 2012-01-01 | NEUROGASTROENTEROLOGY AND MOTILITY | - | 1.01 Articolo in rivista | - |
| Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia | Lucia Catani;Daria Sollazzo;Sara Trabanelli;Antonio Curti;Cecilia Evangelisti;Nicola Polverelli;F...rancesca Palandri;Michele Baccarani;Nicola Vianelli;Roberto Massimo Lemoli | 2013-01-01 | ANNALS OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. | C. Evangelisti; C. Evangelisti; D. Bressanin; F. Buontempo; F. Chiarini; A Lonetti; M Soncin; A.M.... Spartà; J. A. McCubrey; A.M. Martelli. | 2013-01-01 | EXPERT OPINION ON THERAPEUTIC TARGETS | - | 1.01 Articolo in rivista | - |
| ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS | Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Br...essanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am | 2014-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES |
Buontempo F; Orsini E; Cappellini A; Lonetti A; Evangelisti C; Chiarini F; Spartà AM; Bressanin D...; Evangelisti C; Martelli AM |
2014-01-01 | HAEMATOLOGICA | - | 4.03 Poster | - |
| A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer. | Pradella LM;Evangelisti C;Ligorio C;Ceccarelli C;Neri I;Zuntini R;Amato LB;Ferrari S;Martelli AM;...Gasparre G;Turchetti D | 2014-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | 1471-2407-14-70.pdf |
| ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS |
Evangelisti C; Evangelisti C; Teti G; Falconi M; Cappellini A; Chiarini F; Buontempo F; Bressanin... D; Lonetti A; Spartà A; Bittman R; Pyne S; Pyne N; Martelli AM |
2014-01-01 | HAEMATOLOGICA | - | 4.03 Poster | - |
| INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS |
Lonetti A; Cappellini A; Spartà AM; Bressanin D; Buontempo F; Chiarini F; Evangelisti C; Evangel...isti C; Orsini E; Martelli AM |
2014-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling | F. Buontempo; E. Orsini; L.R. Martins; I. Antunes; A. Lonetti; F. Chiarini; G. Tabellini; C. Evan...gelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A. Cappellini; J.T. Barata; A.M. Martelli. | 2014-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. | Trabanelli S; Očadlíková D; Ciciarello M; Salvestrini V; Lecciso M; Jandus C; Metz R; Evangelisti... C; Laury-Kleintop L; Romero P; Prendergast GC; Curti A; Lemoli RM. | 2014-01-01 | JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia | Camilla Evangelisti; Cecilia Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontem...po; Daniela Bressanin; Alessandra Cappellini; Ester Orsini; James A. McCubrey; Alberto Maria Martelli. | 2014-01-01 | INTERNATIONAL JOURNAL OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics. | C. Evangelisti; C. Evangelisti; G. Teti; F. Chiarini; M. Falconi; F. Melchionda; A. Pession; A. B...ertaina; F. Locatelli; J.A. McCubrey; D. J. Beak; R. Bittman; S. Pyne; N.J. Pyne; A.M. Martelli. | 2014-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. | A.M. Spartà; D. Bressanin; F. Chiarini; A. Lonetti; A. Cappellini; C. Evangelisti; C. Evangelisti...; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A.M. Martelli. | 2014-01-01 | CELL CYCLE | - | 1.01 Articolo in rivista | - |
| PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. | Annalisa Lonetti, Alessandra Cappellini, Antonino Maria Spartà, Francesca Chiarini, Francesca Buo...ntempo, Camilla Evangelisti, Cecilia Evangelisti, Ester Orsini, James A. McCubrey, Alberto Maria Martelli | 2015-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | PI3K pan inhibition impairs more efficiently proliferation and survival of T cell acute lymphoblastic leukemia cell lines when compared to isoform selective PI3K inhibitors..pdf |
| A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors | Cecilia Evangelisti;Dario de Biase;Ivana Kurelac;Claudio Ceccarelli;Holger Prokisch;Thomas Meitin...ger;Paola Caria;Roberta Vanni;Giovanni Romeo;Giovanni Tallini;Giuseppe Gasparre;Elena Bonora | 2015-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | 12885_2015_Article_1122.pdf |
| Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. | Cecilia Evangelisti; Camilla Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontem...po; Luca Maria Neri; James A. McCubrey; Alberto Maria Martelli. | 2015-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile